Malaysia gets conditional approval for Moderna Covid-19 vaccine from plant in Spain, says Dr Noor Hisham

In this file photo Moderna vials sit on a table before they are loaded into syringes at a mobile Covid-19 vaccination clinic in Bridgeport, Connecticut, April 20, 2021. Malaysia’s Health Ministry today said it has granted a conditional approval for the Moderna Covid-19 vaccine for emergency use. — AFP pic
In this file photo Moderna vials sit on a table before they are loaded into syringes at a mobile Covid-19 vaccination clinic in Bridgeport, Connecticut, April 20, 2021. Malaysia’s Health Ministry today said it has granted a conditional approval for the Moderna Covid-19 vaccine for emergency use. — AFP pic

Follow us on Instagram and subscribe to our Telegram channel for the latest updates.


KUALA LUMPUR, Aug 5 ― The Drug Control Authority (DCA) in its 362nd meeting today, gave conditional registration approval to Spikevax 0.20 mg/ml Dispersion for Injection Covid-19 mRNA Vaccine (nucleoside modified), also known as Covid-19 Moderna vaccine for use in the current disaster situation.

Health director-general Tan Sri Dr Noor Hisham Abdullah in his statement today said approval for the product was for product registration holder (PRH), Zuellig Pharma Sdn Bhd and the manufacturer, Rovi Pharma Industrial Services of Spain.

“The conditional registration approval required quality information as well as the efficacy of the vaccine to be monitored and evaluated based on the latest data from time to time.     

“It is to ensure the comparison of benefit over risk for the vaccine product remains positive,” he said.

Dr Noor Hisham said the Health Ministry is committed to improve access to the Covid-19 vaccines in Malaysia by ensuring the products are evaluated in terms of quality, safety and effiicacy aspects by the National Pharmaceutical Regulatory Agency (NPRA) and approved by DCA. ― Bernama

You May Also Like

Related Articles